122 related articles for article (PubMed ID: 36415128)
1. A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
Kato T; Tohi Y; Honda T; Matsuda I; Osaki Y; Naito H; Matsuoka Y; Okazoe H; Taoka R; Tsunemori H; Ueda N; Sugimoto M
Int J Urol; 2023 Mar; 30(3):289-297. PubMed ID: 36415128
[TBL] [Abstract][Full Text] [Related]
2. A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients.
Kato T; Tohi Y; Honda T; Matsuda I; Osaki Y; Naito H; Matsuoka Y; Okazoe H; Taoka R; Ueda N; Sugimoto M
Int J Urol; 2023 Aug; 30(8):672-680. PubMed ID: 37350593
[TBL] [Abstract][Full Text] [Related]
3. Editorial Comment on a national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
Kishida T
Int J Urol; 2023 Mar; 30(3):298. PubMed ID: 36653112
[No Abstract] [Full Text] [Related]
4. Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer".
Matsumoto R
Int J Urol; 2023 Mar; 30(3):297. PubMed ID: 36541073
[No Abstract] [Full Text] [Related]
5. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
[TBL] [Abstract][Full Text] [Related]
6. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
Philippou Y; Raja H; Gnanapragasam VJ
BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
[TBL] [Abstract][Full Text] [Related]
8. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
Rubin MA; Bismar TA; Curtis S; Montie JE
Am J Surg Pathol; 2004 Jul; 28(7):946-52. PubMed ID: 15223967
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil.
Wroclawski ML; Amaral BS; Kayano PP; Busato WFS; Westphal SJ; Montagna E; Bianco B; Soares A; Maluf FC; Lemos GC; Carneiro A
BMC Urol; 2022 Jun; 22(1):86. PubMed ID: 35706024
[TBL] [Abstract][Full Text] [Related]
10. Physician Perception of Grade Group 1 Prostate Cancer.
Saoud R; Woranisarakul V; Paner GP; Ramotar M; Berlin A; Cooperberg M; Eggener SE
Eur Urol Focus; 2023 Nov; 9(6):966-973. PubMed ID: 37117112
[TBL] [Abstract][Full Text] [Related]
11. Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
Peabody JW; DeMaria LM; Tamondong-Lachica D; Florentino J; Czarina Acelajado M; Ouenes O; Richie JP; Burgon T
BMC Urol; 2017 Jul; 17(1):51. PubMed ID: 28673277
[TBL] [Abstract][Full Text] [Related]
12. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
[TBL] [Abstract][Full Text] [Related]
13. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
Jain AL; Sidana A; Maruf M; Sugano D; Calio B; Wood BJ; Pinto PA
Urol Oncol; 2019 Mar; 37(3):182.e1-182.e8. PubMed ID: 30522903
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
[TBL] [Abstract][Full Text] [Related]
15. Variability in the multicentre National Registry in Active Surveillance; a questionnaire for urologists.
Rubio-Briones J; Borque-Fernando A; Esteban-Escaño LM; Martínez-Breijo S; Medina-López R; Hernández V;
Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):442-449. PubMed ID: 29661508
[TBL] [Abstract][Full Text] [Related]
16. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
[TBL] [Abstract][Full Text] [Related]
18. Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.
Mitsuzuka K; Koga H; Sugimoto M; Arai Y; Ohyama C; Kakehi Y; Naito S
Int J Urol; 2015 Aug; 22(8):754-9. PubMed ID: 25959857
[TBL] [Abstract][Full Text] [Related]
19. Urologists' personal feelings on PSA screening and prostate cancer treatment.
Wenzler DL; Rosenberg BH
J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
[TBL] [Abstract][Full Text] [Related]
20. Appropriateness Criteria for Active Surveillance of Prostate Cancer.
Cher ML; Dhir A; Auffenberg GB; Linsell S; Gao Y; Rosenberg B; Jafri SM; Klotz L; Miller DC; Ghani KR; Bernstein SJ; Montie JE; Lane BR;
J Urol; 2017 Jan; 197(1):67-74. PubMed ID: 27422298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
